This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovations of Su-er Wu Huskey
Su-er Wu Huskey is an accomplished inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmacology through his innovative research and development. His work primarily focuses on the development of compounds that can aid in the treatment of various disorders.
Latest Patents
Su-er Wu Huskey holds a patent for "Mammalian metabolites of a tachykinin receptor antagonist." This invention is concerned with mammalian metabolites of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)-phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. This tachykinin receptor antagonist is useful in the prevention and treatment of certain disorders, including emesis and psychiatric disorders such as depression and anxiety. His innovative approach has the potential to improve the quality of life for many individuals suffering from these conditions.
Career Highlights
Su-er Wu Huskey is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research. His dedication to innovation and excellence has earned him recognition within the scientific community.
Collaborations
Su-er Wu Huskey has worked alongside Shuet-Hing Lee Chiu, a talented woman in the field. Their collaboration has led to advancements in their research and has fostered a productive working relationship.
Conclusion
In summary, Su-er Wu Huskey is a notable inventor whose work in pharmacology has the potential to make a significant impact on the treatment of various disorders. His innovative patent and collaboration with other experts highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
